Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.

The Journal of rheumatology - 1 Aug 1999

Mongey A B, Sim E, Risch A, Hess E

Abstract excerpt

OBJECTIVE: Autoantibodies occur in the majority of patients receiving procainamide (PA) for more than one year. Slow acetylator status has been proposed to predispose to their development. We previously reported the results of serological evaluation of 52 asymptomatic patients receiving PA. The aims of this study were to follow these patients to determine the incidence of drug related lupus (DRL) and serologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Antinuclear

Share to Autoantibodies

Share to Autoimmunity

Share to Genotype

Share to Phenotype

Source

Identifiers

PMID: 10451068

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.PMID 10451068Read ↗

Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.Semantic proximity Read ↗

Genetic, immunologic and biotransformation studies of patients on procainamide.Semantic proximity Read ↗

Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.Semantic proximity Read ↗

The acetylator phenotype of patients with systemic lupus erythematosus.Semantic proximity Read ↗

Acetylator phenotype and lupus erythematosus.Semantic proximity Read ↗

The lack of relationship between acetylator phenotype and idiopathic systemic lupus erythematosus in a South-east Asian population: a study of Indians, Malays and Malaysian Chinese.Semantic proximity Read ↗

Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic lupus erythematosus.Semantic proximity Read ↗

Lack of association between slow acetylator status and spontaneous lupus erythematosus.Semantic proximity Read ↗

Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.Semantic proximity Read ↗

Acetylation of dapsone by human whole blood.Semantic proximity Read ↗

NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus.Semantic proximity Read ↗

N-acetylation phenotyping using dapsone in a Jordanian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.